Genetic products differentially expressed in tumors and the use thereof

Details for Australian Patent Application No. 2012233044 (hide)

Owner Ganymed Pharmaceuticals AG

Inventors Koslowski, Michael; Tureci, Ozlem; Sahin, Ugur

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2012233044

Parent 2010202440

Filing date 26 September 2012

Wipo publication date 25 October 2012

International Classifications

C07K 14/47 Peptides having more than 20 amino acids

A61K 38/17 Medicinal preparations containing peptides - from animals

A61K 39/00 Medicinal preparations containing antigens or antibodies

C07H 21/00 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 16/30 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

18 October 2012 Complete Application Filed

25 October 2012 Application Open to Public Inspection

  Published as AU-A-2012233044

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012233045-Surgical access device

2012233043-Medical/surgical personal protection system and hood/toga for use therein